Rentabilidad en 3 años
| Fondo | Fecha | |||||
|---|---|---|---|---|---|---|
| 3 años | ||||||
| Resultados por página: 10 | 20 | 50 | 100Se muestran de 1481 a 1490 de un total de 36770 fondos | ||||||
| CANDRIAM EQUITIES L BIOTECHNOLOGY I-H CAP EUR | 30/07 | 69,68% | ||||
| BRANDES EMERGING MARKETS VALUE FUND A USD CAP | 30/07 | 69,67% | ||||
| UBS (LUX) KEY SELECTION SICAV - EUROPEAN EQUITY VALUE OPPORTUNITY (EUR) Q-ACC | 30/07 | 69,67% | ||||
| PRIVILEDGE - FIDELITY TECHNOLOGY (USD) I CAP | 29/07 | 69,66% | ||||
| POLAR CAPITAL JAPAN VALUE I GBP DIS | 30/07 | 69,64% | ||||
| MFS MERIDIAN CONTRARIAN VALUE FUND W1-GBP | 30/07 | 69,60% | ||||
| SCHRODER ISF FRONTIER MARKETS EQUITY C ACC GBP | 30/07 | 69,59% | ||||
| FIDELITY FUNDS-JAPAN GROWTH Y-ACC-EUR (HEDGED) | 30/07 | 69,55% | ||||
| GOLDMAN SACHS EUROPE CORE EQUITY PORTFOLIO I CHF CAP | 30/07 | 69,55% | ||||
| INVESCO EQQQ NASDAQ-100 UCITS ETF EUR HEDGED ACC | 30/07 | 69,55% | ||||
